2026 Call for Abstracts-Pittsburgh International Lung Conference

  • 2026 Call for Abstracts

    The Pittsburgh International Lung Conference is currently accepting submissions of scientific abstracts on all aspects of respiratory conditions, pulmonary disease, critical care, and sleep medicine.

  • Submission Guidelines:

    Abstract submissions should be a maximum 600 words, 11pt, Arial font.

    A maximum of two jpegs or figures embedded within the document are acceptable but should be clear resolution.

    Please upload your final document without editing markup included. Word documents are preferred, but PDF's will be accepted. 

    All files should be less than 5MB. 

    The abstract format should follow the standard guidelines below:

    -Abstract Title
    -Full Author List with first author underlined and an asterisk (*) by the presenting author's name
    -Author Affiliations

    -Background, Introduction, or Rationale
    -Objective or Hypothesis 
    -Materials and/or Methods
    -Results and/or Discussion
    -Conclusions
    -Research Funding (if applicable)

    All are invited to attend the conference, regardless of abstract submission status.  However, registration is mandatory for everyone who plans to attend the conference, including presenting authors of accepted abstracts.

    All expenses associated with abstract submission and poster presentation are the presenter’s responsibility.

    Multiple abstracts from one laboratory are permitted.  However, only one abstract may be submitted per person.

    Authors should not split data to create several abstracts from the same work. If splitting is judged to have occurred, acceptance of all abstracts may be jeopardized.

    Case studies, literature reviews, and/or industry abstracts will not be accepted.

    Abstracts that have been submitted to other conferences (ATS, CHEST, AHA, etc.) are permissible, but should contain new data.

    Abstracts should not contain proprietary or confidential information.

    If a drug has a generic version, the generic name(s) should be used for all drugs that qualify. If using brand names, they should be company agnostic, not promotional, and consistent throughout your abstract(s) and presenting poster.

    Abstracts are accepted based on scientific merit and originality.

    The deadline for abstract submission is Saturday, August 1 (midnight EST).

  • Academic Degree/s
  • Is the first author a current ALA member?*
  • Current Position
  • Will the First Author also be the PRESENTING author of this poster during the conference?*
  • PRESENTING Author's Academic Degree/s
  • Is the presenting author a current ALA member?*
  • Presenting Author's Current Position
  • Would you like this abstract to be considered for a short, oral presentation within the main conference sessions?*
  • Click to upload
    Drag and drop files here
    Choose a file
    Cancelof

  • Please note:

    Accepted abstracts will be reproduced and included in the conference handout.  Submission of your abstract signifies consent of print and distribution of those materials.

    Submission of an abstract by a presenting author certifies that ALL authors are aware of and have agreed to have the abstract submitted and published in the conference handout.

    Submission constitutes a commitment from the author(s) to present their poster if the abstract is accepted. Presenting authors are required to register for the conference.

    The author submitting the abstract should be the abstract presenter, if accepted. The conference committee only sends notifications to the submitting author.

    All expenses associated with registration, submission, and presentation of the abstract are the presenter’s responsibility.

    Requests for withdrawal of an accepted abstract must be received by the PILC in writing at dobranskyta@upmc.edu by August 29.

  • Should be Empty: